tiprankstipranks
Trending News
More News >

Fundss - New Portfolio

Tali01

Fundss
Individual Investor
Ranked #287,121 out of 826,208 TipRanks' Investors
Success Rate
64%
34 out of 53
profitable transactions
Average Return
10.47%
Average return
per transaction
Share this portfolio:

Portfolio Gain

1-Month Return▲ 21.03%
6-Month Return▲ 684.57%
12-Month Return▲ 778.59%
YTD Return▲ 770.75%
Total Return▲ 1770.76%

Best Trade

Opened at
Closed at-
Gain▲ 159.88%

Bio

Performance

757.26%0-757.26%
▼ 6.38%
▼ 5.57%
▼ 11.56%
Mar 2025
▲ 0.80%
▼ 0.87%
▼ 24.52%
Apr 2025
▲ 11.63%
▲ 6.28%
▲ 757.26%
May 2025
▲ 9.25%
▲ 5.14%
▲ 10.48%
Jun 2025
▲ 7.60%
▲ 2.30%
▼ 0.66%
Jul 2025
▲ 2.76%
▲ 2.05%
▲ 14.04%
Aug 2025
▲ 12.88%
▲ 3.56%
▼ 0.44%
Sep 2025
▲ 10.96%
▲ 2.38%
▲ 23.29%
Oct 2025
TipRanks AverageS&P 500Investor Portfolio
▼ 6.38%▼ 5.57%▼ 11.56%
▲ 0.80%▼ 0.87%▼ 24.52%
▲ 11.63%▲ 6.28%▲ 757.26%
▲ 9.25%▲ 5.14%▲ 10.48%
▲ 7.60%▲ 2.30%▼ 0.66%
▲ 2.76%▲ 2.05%▲ 14.04%
▲ 12.88%▲ 3.56%▼ 0.44%
▲ 10.96%▲ 2.38%▲ 23.29%

Recent Activity

Company Name
% of Portfolio
Return
No. of Transactions
Last Transaction
Date
Apple
0%
▲ 14.72%
12
Open
Sep 03, 2025
Alibaba
0%
▲ 24.90%
1
Open
Sep 03, 2025
Meta Platforms
0%
▼ 6.60%
3
Open
Sep 01, 2025
Royal Bank Of Canada
0%
▲ 3.72%
1
Open
Sep 01, 2025
Alkami Technology
0%
▼ 17.39%
1
Open
Sep 01, 2025
iShares MSCI UAE ETF
0.01%
▼ 0.76%
1
Open
Aug 24, 2025
Ethereum
0%
▲ 0.47%
1
Open
Jul 30, 2025
AppLovin
0%
▲ 75.42%
1
Open
Jul 30, 2025
Simmons 1st Nat'l
0%
▼ 11.30%
1
Open
Jul 29, 2025
PepsiCo
0%
▲ 2.52%
1
Open
Jul 29, 2025
Charles Schwab
0%
▲ 3.97%
1
Open
Jul 01, 2025
Charles & Colvard
▼ 78.82%
2
Close
Jun 05, 2025
Anixa Biosciences
▲ 10.95%
3
Close
May 28, 2025
Fundamental Investors, Class A Shares
0%
▲ 22.89%
1
Open
Mar 19, 2025
Ish.Frf Heal Gl
0.01%
▼ 1.21%
1
Open
Mar 03, 2025
Amplify High Income ETF
▲ 19.48%
2
Close
Jan 23, 2025
Datasea
0.00%
2
Close
Jan 23, 2025
Invesco QQQ Trust
▲ 4.07%
4
Close
Jan 23, 2025
WF Absolute Return Fd Cl A
▼ 5.32%
2
Close
Jan 23, 2025
Vertex Pharmaceuticals
▼ 7.65%
2
Close
Jan 23, 2025